IP Management

How Intellectual Property is Managed by BioVentures, Licensees, and Inventors

BioVentures’ strives to maximize the industrial interactions for UAMS by developing commercial partnership to facilitate technology transfer, create startup biotech companies, and improve Arkansas’ economic development. BioVentures is the hub connecting UAMS’ basic research to the global life sciences industry.

After an inventor files an Invention Disclosure Form, the Patent and Copyright Committee meet with the inventor to discuss the technology and its merits.  The Committee considers patentability, research value, commercialization potential, and eventual end benefit to science and to the community at large.

The Patent and Copyright Committee vote whether BioVentures will decide which type of intellectual property protection (Patent, Trademark, Copyright, or even Trade Secret) is most appropriate for the technology if the Committee decides to move forward with the technology.  If the Committee does not move forward with the technology, the rights to the technology are given to the inventors (unless a research funding sponsor has first rights).

BioVentures then oversees the pursuit of intellectual property protection (Patent Prosecution or Copyright/Trademark filing).

The intellectual property, even if still pending, is then either licensed to an established company for further development or becomes the basis of a BioVentures company where it can be developed and commercialized from the Business Incubator arm of BioVentures.

Patenting, Technology Transfer and Commercialization Workshops are available for you or your department, please call BioVentures (686-6696) to schedule this opportunity.